
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.08 | -6.95652173913 | 1.15 | 1.2 | 0.96 | 8332 | 1.06470163 | CS |
4 | -0.5 | -31.847133758 | 1.57 | 1.61 | 0.96 | 8252 | 1.2874203 | CS |
12 | -0.31 | -22.4637681159 | 1.38 | 1.8 | 0.8001 | 32664 | 1.39854471 | CS |
26 | -0.65 | -37.7906976744 | 1.72 | 3.08 | 0.8001 | 19386 | 1.5481953 | CS |
52 | -1.78 | -62.4561403509 | 2.85 | 3.3 | 0.8001 | 12347 | 1.76759736 | CS |
156 | -5.65 | -84.0773809524 | 6.72 | 7.88 | 0.8001 | 10660 | 2.70111432 | CS |
260 | -6.31 | -85.5013550136 | 7.38 | 9.33 | 0.8001 | 11154 | 3.83521837 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約